海王生物(000078.SZ):擬引入南水北調基金對子公司增資
格隆匯4月27日丨海王生物(000078.SZ)公佈,為進一步提升公司子公司河南東森、河南匯通綜合實力,優化其資產負債結構,增強市場競爭力,促進其業務發展,公司擬引入投資方南水北調基金對河南東森和河南海王匯通進行增資。
其中:南水北調基金擬以人民幣7200萬元對河南東森進行增資,人民幣1080萬元計入河南東森新增註冊資本,人民幣6120萬元計入河南東森資本公積金,增資完成後南水北調基金持有河南東森6.72%股權。
南水北調基金擬以人民幣2800萬元對河南海王匯通進行增資,人民幣435萬元計入河南海王匯通新增註冊資本,人民幣2365萬元計入河南海王匯通資本公積金,增資完成後南水北調基金持有河南海王匯通8%股權。
公司子公司河南海王集團放棄此次優先認繳出資權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.